Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients (ARTE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by The Huesped Foundation
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Pedro Cahn, The Huesped Foundation Identifier:
First received: April 8, 2013
Last updated: September 4, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)